TG Therapeutics, Inc. - Common Stock (NQ:TGTX)
Price and Volume
Detailed Quote| Volume | 1,978,236 |
| Open | 52.56 |
| Bid (Size) | 53.99 (100) |
| Ask (Size) | 54.40 (800) |
| Prev. Close | 53.16 |
| Today's Range | 51.83 - 55.80 |
| 52wk Range | 26.76 - 59.30 |
| Shares Outstanding | 154,420,772 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
8.7% below 52-week high
54.17
26.7652W Low
59.3052W High
1 Week
2.9% below 1-week high
51.831W Low
55.801W High
TG Therapeutics, Inc. - Common Stock (TGTX) traded between $26.76 and $59.30 over the past 52 weeks and last traded at $54.17, 8.7% below its 52-week high. Over the past week it ranged between $51.83 and $55.80.
Past 12 Months
+1.6%
-5.8%
-2.8%
+53.1%
+85.0%
+62.5%
1W
+$0.87
1M
-$3.35
3M
-$1.58
6M
+$18.79
YTD
+$24.89
1Y
+$20.84
TGTX was +62.5% over the past year, +53.1% over six months, +85.0% year to date, +1.6% in the last week.
12 Months vs Market
TGTX
+62.5%
DIA
+10.4%
SPY
+12.2%
QQQ
+14.1%
IWM
+10.6%
Over the past 12 months TGTX returned +62.5% versus DIA (Dow) +10.4%, SPY (S&P 500) +12.2%, QQQ (Nasdaq 100) +14.1% and IWM (Russell 2000) +10.6%.
Volume & Liquidity
1.02× 3-mo avg
Today 1,978,236
3-mo avg 1.9M
1W
1.4M
1M
1.5M
3M
1.9M
6M
2.2M
YTD
2.1M
1Y
2.1M
TGTX most recently traded 1,978,236 shares against a 3-month average daily volume of 1.9M.
More News
Read More
Via Chartmill
Via Chartmill
Via Business Wire
TG Therapeutics Eyes $1B Run Rate as BRIUMVI Gains MS Market Share ↗
September 18, 2026
Via MarketBeat
Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market
September 10, 2026
From BioMedWire
Via GlobeNewswire
TG Therapeutics (TGTX) Q2 2026 Earnings Call Transcript ↗
August 10, 2026
Via The Motley Fool
Topics
Earnings
TG Therapeutics Q2 Earnings Call Highlights ↗
August 03, 2026
Via MarketBeat
Topics
Earnings
2 Fast-Growing Pharmaceutical Stocks to Buy Now ↗
July 08, 2026
Via The Motley Fool
The Quest to Repair What Multiple Sclerosis Takes Away
June 24, 2026
The Quest to Repair What Multiple Sclerosis Takes Away
June 24, 2026
From BioMedWire
Via GlobeNewswire
TG Therapeutics Stock Surges After Drug Trial Update ↗
June 03, 2026
Via Benzinga
Frequently Asked Questions
Is TG Therapeutics, Inc. - Common Stock publicly traded?
Yes, TG Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does TG Therapeutics, Inc. - Common Stock trade on?
TG Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for TG Therapeutics, Inc. - Common Stock?
The ticker symbol for TG Therapeutics, Inc. - Common Stock is TGTX on the Nasdaq Stock Market
What is the current price of TG Therapeutics, Inc. - Common Stock?
The current price of TG Therapeutics, Inc. - Common Stock is 54.17
When was TG Therapeutics, Inc. - Common Stock last traded?
The last trade of TG Therapeutics, Inc. - Common Stock was at 10/23/26 04:00 PM ET
What is the market capitalization of TG Therapeutics, Inc. - Common Stock?
The market capitalization of TG Therapeutics, Inc. - Common Stock is 8.36B
How many shares of TG Therapeutics, Inc. - Common Stock are outstanding?
TG Therapeutics, Inc. - Common Stock has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>